Stock ACCP ACCESS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Access Pharmaceuticals, Inc. OTC Bulletin Board

Equities

ACCP

US00431M3088

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Access Pharmaceuticals, Inc.
May. 03 Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise MT
Apr. 23 Sector Update: Health Care Stocks Rise Late Afternoon MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
AQ
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
AQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
BU
Law Offices of Howard G. Smith Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
BU
The Law Offices of Frank R. Cruz Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
BU
Abeona Therapeutics Provides Regulatory Update on Pz-cel
AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
AQ
Abeona Therapeutics Announces New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)
AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
AQ
Abeona Therapeutics Announces $50 Million Credit Facility
AQ
Abeona Therapeutics Announces New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)
AQ
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application
AQ
Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application (BLA)
AQ
Abeona Therapeutics: Q3 Earnings Snapshot
AQ
Abeona Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Developments
AQ
Abeona Therapeutics Announces New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABEO Stock
  4. ACCP Stock
  5. News Access Pharmaceuticals, Inc.
  6. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW